Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$1.66 - $2.31 $14 - $20
-9 Reduced 12.5%
63 $0
Q2 2023

Aug 11, 2023

BUY
$1.61 - $1.96 $51 - $62
32 Added 80.0%
72 $0
Q4 2022

Feb 13, 2023

BUY
$2.05 - $5.5 $22 - $60
11 Added 37.93%
40 $0
Q3 2022

Nov 14, 2022

BUY
$0.94 - $5.99 $27 - $173
29 New
29 $0

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.